316 related articles for article (PubMed ID: 10873480)
21. Sulfatides activate platelets through P-selectin and enhance platelet and platelet-leukocyte aggregation.
Merten M; Beythien C; Gutensohn K; Kühnl P; Meinertz T; Thiagarajan P
Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):258-63. PubMed ID: 15528476
[TBL] [Abstract][Full Text] [Related]
22. Flow cytometry detection of platelet procoagulation activity and microparticles in patients with unstable angina treated by percutaneous coronary angioplasty and stent implantation.
Vidal C; Spaulding C; Picard F; Schaison F; Melle J; Weber S; Fontenay-Roupie M
Thromb Haemost; 2001 Sep; 86(3):784-90. PubMed ID: 11583308
[TBL] [Abstract][Full Text] [Related]
23. Changes in glycoprotein expression after platelet activation: differences between in vitro and in vivo studies.
Escolar G; White JG
Thromb Haemost; 2000 Mar; 83(3):371-86. PubMed ID: 10744140
[No Abstract] [Full Text] [Related]
24. Flow cytometric analysis of circulating platelet-monocyte aggregates in whole blood: methodological considerations.
Harding SA; Din JN; Sarma J; Jessop A; Weatherall M; Fox KA; Newby DE
Thromb Haemost; 2007 Aug; 98(2):451-6. PubMed ID: 17721630
[TBL] [Abstract][Full Text] [Related]
25. Clopidogrel but not aspirin reduces P-selectin expression and formation of platelet-leukocyte aggregates in patients with atherosclerotic vascular disease.
Klinkhardt U; Bauersachs R; Adams J; Graff J; Lindhoff-Last E; Harder S
Clin Pharmacol Ther; 2003 Mar; 73(3):232-41. PubMed ID: 12621388
[TBL] [Abstract][Full Text] [Related]
26. GPV is a marker of in vivo platelet activation--study in a rat thrombosis model.
Ravanat C; Freund M; Mangin P; Azorsa DO; Schwartz C; Moog S; Schuhler S; Dambach J; Cazenave JP; Lanza F
Thromb Haemost; 2000 Feb; 83(2):327-33. PubMed ID: 10739394
[TBL] [Abstract][Full Text] [Related]
27. Effect of prostacyclin on platelets, polymorphonuclear cells, and heterotypic cell aggregation during hemofiltration.
Kozek-Langenecker SA; Spiss CK; Michalek-Sauberer A; Felfernig M; Zimpfer M
Crit Care Med; 2003 Mar; 31(3):864-8. PubMed ID: 12626998
[TBL] [Abstract][Full Text] [Related]
28. Imaging flow cytometry in the assessment of leukocyte-platelet aggregates.
Hui H; Fuller KA; Erber WN; Linden MD
Methods; 2017 Jan; 112():46-54. PubMed ID: 27720831
[TBL] [Abstract][Full Text] [Related]
29. Leukocyte-platelet aggregates in acute and subacute ischemic stroke.
Marquardt L; Anders C; Buggle F; Palm F; Hellstern P; Grau AJ
Cerebrovasc Dis; 2009; 28(3):276-82. PubMed ID: 19609079
[TBL] [Abstract][Full Text] [Related]
30. Platelet GPIIb/IIIa is activated and platelet-leukocyte coaggregates formed in vivo during hemodialysis.
Kawabata K; Nakai S; Miwa M; Sugiura T; Otsuka Y; Shinzato T; Hiki Y; Tomimatsu I; Ushida Y; Hosono F; Maeda K
Nephron; 2002 Apr; 90(4):391-400. PubMed ID: 11961397
[TBL] [Abstract][Full Text] [Related]
31. The state of platelets preserved in extracorporeal circulation with a glycoprotein IIb/IIIa inhibitor.
Kondo N; Wakayama F; Suzuki Y; Fukui K; Takaya S; Fukuda I
Thromb Res; 2004; 113(5):303-10. PubMed ID: 15183042
[TBL] [Abstract][Full Text] [Related]
32. Platelet activation and progression to complications.
Kereiakes DJ; Michelson AD
Rev Cardiovasc Med; 2006; 7(2):75-81. PubMed ID: 16915126
[TBL] [Abstract][Full Text] [Related]
33. A new genetic isolate of gray platelet syndrome (GPS): clinical, cellular, and hematologic characteristics.
Falik-Zaccai TC; Anikster Y; Rivera CE; Horne MK; Schliamser L; Phornphutkul C; Attias D; Hyman T; White JG; Gahl WA
Mol Genet Metab; 2001 Nov; 74(3):303-13. PubMed ID: 11708859
[TBL] [Abstract][Full Text] [Related]
34. Monoclonal antibodies against platelet membrane glycoproteins IIb/IIIa and Ibalpha inhibit platelet dependent thrombin generation by different mechanisms.
Thomas S; Metcalfe P; Goodall AH; Gray E
Thromb Haemost; 2000 Jul; 84(1):98-103. PubMed ID: 10928478
[TBL] [Abstract][Full Text] [Related]
35. Effects of physiologic agonists on canine whole blood flow cytometry assays of leukocyte-platelet aggregation and platelet activation.
Tarnow I; Kristensen AT; Krogh AK; Frelinger AL; Barnard MR; Michelson AD
Vet Immunol Immunopathol; 2008 Jun; 123(3-4):345-52. PubMed ID: 18405981
[TBL] [Abstract][Full Text] [Related]
36. Both CD62 and CD162 antibodies prevent formation of CD36-dependent platelets, rosettes, and artefactual pseudoexpression of platelet markers on white blood cells: a study with ImageStream®.
Ouk C; Jayat-Vignoles C; Donnard M; Feuillard J
Cytometry A; 2011 Jun; 79(6):477-84. PubMed ID: 21462306
[TBL] [Abstract][Full Text] [Related]
37. [Detection of activated platelets by flow cytometry].
Kohmura C; Hayashi Y; Ikeda H
Rinsho Byori; 1999 May; 47(5):447-52. PubMed ID: 10375966
[TBL] [Abstract][Full Text] [Related]
38. Haemodialysis and platelet activation.
Deguchi N; Ohigashi T; Tazaki H; Handa M; Ikeda Y
Nephrol Dial Transplant; 1991; 6 Suppl 2():40-2. PubMed ID: 1714062
[No Abstract] [Full Text] [Related]
39. In comparison to progenitor platelets, microparticles are deficient in GpIb, GpIb-derived carbohydrates, glycerophospholipids, glycosphingolipids, and ceramides.
Zdebska E; Woźniak J; Dzieciatkowska A; Kościelak J
Acta Biochim Pol; 1998; 45(2):417-28. PubMed ID: 9821872
[TBL] [Abstract][Full Text] [Related]
40. A multicolor flow cytometric assay for measurement of platelet-derived microparticles.
Mobarrez F; Antovic J; Egberg N; Hansson M; Jörneskog G; Hultenby K; Wallén H
Thromb Res; 2010 Mar; 125(3):e110-6. PubMed ID: 19939440
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
